Literature DB >> 11012169

Cytokine gene transfer in cancer therapy.

L Cao1, P Kulmburg, H Veelken, A Mackensen, B Mézes, A Lindemann, R Mertelsmann, F M Rosenthal.   

Abstract

New strategies based on gene transfer technology are employed in cancer therapy. Cytokines are polypeptides involved in immunity and inflammation, and essentially control the magnitude of the immune response. Genetically modified tumor cells releasing various cytokines have been shown to enhance tumor immunogenicity and to induce the regression of preexisting tumors. In some instances, immunological memory has been generated to resist the subsequent challenge with unmodified, parental tumor cells. Cytokine gene transfer into antitumor effector cells, as well as antigen presenting cells, is also being investigated to augment antitumor immune responses.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 11012169     DOI: 10.1002/stem.5530160831

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  6 in total

1.  Cytokine-related genes identified from the RIKEN full-length mouse cDNA data set.

Authors:  Vladimir Brusic; Rekha S Pillai; Diego G Silva; Nikolai Petrovsky; Christian Schönbach
Journal:  Genome Res       Date:  2003-06       Impact factor: 9.043

2.  IL36 Cooperates With Anti-CTLA-4 mAbs to Facilitate Antitumor Immune Responses.

Authors:  Qiuxia Qu; Zhiwei Zhai; Jieni Xu; Song Li; Cheng Chen; Binfeng Lu
Journal:  Front Immunol       Date:  2020-04-15       Impact factor: 7.561

Review 3.  Immunotherapy for liver tumors: present status and future prospects.

Authors:  Pablo Matar; Laura Alaniz; Viviana Rozados; Jorge B Aquino; Mariana Malvicini; Catalina Atorrasagasti; Manuel Gidekel; Marcelo Silva; O Graciela Scharovsky; Guillermo Mazzolini
Journal:  J Biomed Sci       Date:  2009-03-06       Impact factor: 8.410

4.  Effects of long-term oral administration of arachidonic acid and docosahexaenoic acid on the immune functions of young rats.

Authors:  Sachiko Juman; Michio Hashimoto; Masanori Katakura; Takayuki Inoue; Yoko Tanabe; Makoto Arita; Tomohiro Miki; Osamu Shido
Journal:  Nutrients       Date:  2013-05-29       Impact factor: 5.717

5.  Hapten-enhanced overall survival time in advanced hepatocellular carcinoma by ultro-minimum incision personalized intratumoral chemoimmunotherapy.

Authors:  Feng Gao; Peng Jing; Jian Liu; Yuanfei Lu; Peicheng Zhang; Wei Han; Guoliang Liu; Ning Ru; Guanghui Cui; Chenglin Sun; Yebing Che; Huaming Zhang; Qnglong Hu; Huan-You Wang; Yingli Wu; Changjiang Guan; Qiang Fu; Zhenlu Ma; Baofa Yu
Journal:  J Hepatocell Carcinoma       Date:  2015-06-10

Review 6.  Nucleic Acid-Based Approaches for Tumor Therapy.

Authors:  Simone Hager; Frederic Julien Fittler; Ernst Wagner; Matthias Bros
Journal:  Cells       Date:  2020-09-09       Impact factor: 6.600

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.